The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Today, 3:52 PM
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 11)
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Today, 3:52 PM
Here's a roundup of top developments in the biotech space over the last 24 hours.
Click here for accessing Benzinga's FDA Calendar
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 30)
ADMA Biologics’s Return On Capital Employed Overview
Today, 3:52 PM
ADMA Biologics (NASDAQ:ADMA) brought in sales totaling $17.83 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 2.75%, resulting in a loss of $15.58 million.
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
Today, 3:52 PM
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 14)
ADMA Biologics Shares Spike On Volume, Co. Files U.S. Patent Application For ‘IMMUNOTHERAPEUTIC COMPOSITIONS AND METHODS OF PRODUCTION FOR CORONAVIRUS’
Today, 3:52 PM
https://pdfaiw.uspto.gov/.aiw?PageNum=0&docid=20210277093
Benzinga Pro’s Top 5 Stocks To Watch For Wednesday, Sept. 8, 2021: KR, COUP, ADMA, UPST, NIO
Today, 3:52 PM
Today's 5 Stock Ideas:
Kroger (KR) - The Kroger Co reports Q2 earnings on Friday, September 10th.
Coupa Software (COUP) - Shares up ~3.6% premarket. The company reported Q2 earnings results
ADMA Biologics’ Aseptic Fill-Finish Machine Scores FDA Approval
Today, 3:52 PM
The FDA has approved ADMA Biologics Inc’s (NASDAQ:ADMA) in-house aseptic fill-finish machine, the VanRx SA25. Related Content: ADMA Biologics Stock Gains On…
The Daily Biotech Pulse: MacroGenics’ Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA’s FDA Nod
Today, 3:52 PM
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 7)